🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I've decided to use my account to share work from dancers and choreographers whose art has contributed to my love of dance! To start off: "Caught" - created in 1982 by David Parsons Parsons Dance showcases stunning lighting/strobe effects. vimeo.com/161029541

BREAKING - Today, the Public Employment Relations Board verified that a majority of UC Student Researchers have voted to form a union.

BREAKING: UC agrees to recognize SRU-UAW in its entirety! This historic victory was brought about by the tireless efforts of thousands of SRs who organized to win a union & a direct response to our massive Strike Authorization Vote. Now let’s win a strong contract for all SRs!

Excited to share our work on FEM1B tomorrow alongside my amazing co-author Andrew Manford! at 9am PST

So excited and grateful to have worked on this project with so many people! Thank you everyone, especially to Dan Nomura and Nathaniel Henning and all of our collaborators!

A novel methodology for using tyrosinase to synthesize protein−cell conjugates while retaining cell viability and function. NEW #ASAP by Matthew Francis & team Francis Group 🧪 Read here: go.acs.org/1Ay

Introducing Vicinitas Therapeutics, a new venture focused on advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in #cancer and genetic disorders. Learn more about Vicinitas' mission from founder Dan Nomura. businesswire.com/news/home/2022…

Check out job postings at our website vicinitastx.com for our new DUBTAC company, Vicinitas Therapeutics for targeted protein stabilization!!

Vicinitas launches with $65 million for protein stabilization cen.acs.org/business/start… via C&EN (Chemical & Engineering News)

So excited and lucky to be a part of Vicinitas to work on targeted protein stabilization! We are growing our team so we can develop this platform into a technology that will hopefully transform how we treat many diseases.

So grateful for the opportunity to work on this with Nathaniel Henning and Dan Nomura -- I learned so much about covalent drug discovery and became a much better writer through the process. And of course, so glad to share another project with my friend and colleague Nathaniel Henning :)